TY - JOUR A1 - Fagan, Jeremy K. A1 - Dollar, Gretchen A1 - Lu, Qiuheng A1 - Barnett, Austen A1 - Jorge, Joaquin Pechuan A1 - Schlosser, Andreas A1 - Pfleger, Cathie A1 - Adler, Paul A1 - Jenny, Andreas T1 - Combover/CG10732, a Novel PCP Effector for Drosophila Wing Hair Formation JF - PLOS ONE N2 - The polarization of cells is essential for the proper functioning of most organs. Planar Cell Polarity (PCP), the polarization within the plane of an epithelium, is perpendicular to apical-basal polarity and established by the non-canonical Wnt/Fz-PCP signaling pathway. Within each tissue, downstream PCP effectors link the signal to tissue specific readouts such as stereocilia orientation in the inner ear and hair follicle orientation in vertebrates or the polarization of ommatidia and wing hairs in Drosophila melanogaster. Specific PCP effectors in the wing such as Multiple wing hairs (Mwh) and Rho Kinase (Rok) are required to position the hair at the correct position and to prevent ectopic actin hairs. In a genome-wide screen in vitro, we identified Combover (Cmb)/CG10732 as a novel Rho kinase substrate. Overexpression of Cmb causes the formation of a multiple hair cell phenotype (MHC), similar to loss of rok and mwh. This MHC phenotype is dominantly enhanced by removal of rok or of other members of the PCP effector gene family. Furthermore, we show that Cmb physically interacts with Mwh, and cmb null mutants suppress the MHC phenotype of mwh alleles. Our data indicate that Cmb is a novel PCP effector that promotes to wing hair formation, a function that is antagonized by Mwh. KW - planar cell polarity KW - RHO-associated kinease KW - convergent extension movements KW - ROK-alpha KW - protein KW - phosphorylation KW - actin KW - gene KW - morphogenesis KW - localization Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-115394 SN - 1932-6203 VL - 9 IS - 9 ER - TY - JOUR A1 - Eisenhardt, Anja E. A1 - Sprenger, Adrian A1 - Röring, Michael A1 - Herr, Ricarda A1 - Weinberg, Florian A1 - Köhler, Martin A1 - Braun, Sandra A1 - Orth, Joachim A1 - Diedrich, Britta A1 - Lanner, Ulrike A1 - Tscherwinski, Natalja A1 - Schuster, Simon A1 - Dumaz, Nicolas A1 - Schmidt, Enrico A1 - Baumeister, Ralf A1 - Schlosser, Andreas A1 - Dengjel, Jörn A1 - Brummer, Tilman T1 - Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles JF - Oncotarget N2 - B-Raf represents a critical physiological regulator of the Ras/RAF/MEK/ERK-pathway and a pharmacological target of growing clinical relevance, in particular in oncology. To understand how B-Raf itself is regulated, we combined mass spectrometry with genetic approaches to map its interactome in MCF-10A cells as well as in B-Raf deficient murine embryonic fibroblasts (MEFs) and B-Raf/Raf-1 double deficient DT40 lymphoma cells complemented with wildtype or mutant B-Raf expression vectors. Using a multi-protease digestion approach, we identified a novel ubiquitination site and provide a detailed B-Raf phospho-map. Importantly, we identify two evolutionary conserved phosphorylation clusters around T401 and S419 in the B-Raf hinge region. SILAC labelling and genetic/biochemical follow-up revealed that these clusters are phosphorylated in the contexts of oncogenic Ras, sorafenib induced Raf dimerization and in the background of the V600E mutation. We further show that the vemurafenib sensitive phosphorylation of the T401 cluster occurs in trans within a Raf dimer. Substitution of the Ser/Thr-residues of this cluster by alanine residues enhances the transforming potential of B-Raf, indicating that these phosphorylation sites suppress its signaling output. Moreover, several B-Raf phosphorylation sites, including T401 and S419, are somatically mutated in tumors, further illustrating the importance of phosphorylation for the regulation of this kinase. KW - BRAF KW - proteomics KW - phosphorylation KW - sorafenib KW - protein-protein interaction Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-166529 VL - 7 IS - 18 ER - TY - JOUR A1 - Eberlein, Uta A1 - Peper, Michel A1 - Fernández, Maria A1 - Lassmann, Michael A1 - Scherthan, Harry T1 - Calibration of the \(\gamma\)-H2AX DNA double strand break focus assay for internal radiation exposure of blood lymphocytes JF - PLoS ONE N2 - DNA double strand break (DSB) formation induced by ionizing radiation exposure is indicated by the DSB biomarkers \(\gamma\)-H2AX and 53BP1. Knowledge about DSB foci formation in-vitro after internal irradiation of whole blood samples with radionuclides in solution will help us to gain detailed insights about dose-response relationships in patients after molecular radiotherapy (MRT). Therefore, we studied the induction of radiation-induced co-localizing \(\gamma\)-H2AX and 53BP1 foci as surrogate markers for DSBs in-vitro, and correlated the obtained foci per cell values with the in-vitro absorbed doses to the blood for the two most frequently used radionuclides in MRT (I-131 and Lu-177). This approach led to an in-vitro calibration curve. Overall, 55 blood samples of three healthy volunteers were analyzed. For each experiment several vials containing a mixture of whole blood and radioactive solutions with different concentrations of isotonic NaCl-diluted radionuclides with known activities were prepared. Leukocytes were recovered by density centrifugation after incubation and constant blending for 1 h at 37°C. After ethanol fixation they were subjected to two-color immunofluorescence staining and the average frequencies of the co-localizing \(\gamma\)-H2AX and 53BP1 foci/nucleus were determined using a fluorescence microscope equipped with a red/green double band pass filter. The exact activity was determined in parallel in each blood sample by calibrated germanium detector measurements. The absorbed dose rates to the blood per nuclear disintegrations occurring in 1 ml of blood were calculated for both isotopes by a Monte Carlo simulation. The measured blood doses in our samples ranged from 6 to 95 mGy. A linear relationship was found between the number of DSB-marking foci/nucleus and the absorbed dose to the blood for both radionuclides studied. There were only minor nuclide-specific intra-and inter-subject deviations. KW - in vivo formation KW - chromatin mobility KW - phosphorylation KW - repair KW - 53BP1 KW - damage KW - radioiodine therapy KW - thyroid cancer KW - histone H2AX KW - dose response Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-148697 VL - 10 IS - 4 ER - TY - JOUR A1 - Dusik, Verena A1 - Senthilan, Pingkalai R. A1 - Mentzel, Benjamin A1 - Hartlieb, Heiko A1 - Wülbeck, Corina A1 - Yoshii, Taishi A1 - Raabe, Thomas A1 - Helfrich-Förster, Charlotte T1 - The MAP Kinase p38 Is Part of Drosophila melanogaster's Circadian Clock JF - PLoS Genetics N2 - All organisms have to adapt to acute as well as to regularly occurring changes in the environment. To deal with these major challenges organisms evolved two fundamental mechanisms: the p38 mitogen-activated protein kinase (MAPK) pathway, a major stress pathway for signaling stressful events, and circadian clocks to prepare for the daily environmental changes. Both systems respond sensitively to light. Recent studies in vertebrates and fungi indicate that p38 is involved in light-signaling to the circadian clock providing an interesting link between stress-induced and regularly rhythmic adaptations of animals to the environment, but the molecular and cellular mechanisms remained largely unknown. Here, we demonstrate by immunocytochemical means that p38 is expressed in Drosophila melanogaster's clock neurons and that it is activated in a clock-dependent manner. Surprisingly, we found that p38 is most active under darkness and, besides its circadian activation, additionally gets inactivated by light. Moreover, locomotor activity recordings revealed that p38 is essential for a wild-type timing of evening activity and for maintaining ∼ 24 h behavioral rhythms under constant darkness: flies with reduced p38 activity in clock neurons, delayed evening activity and lengthened the period of their free-running rhythms. Furthermore, nuclear translocation of the clock protein Period was significantly delayed on the expression of a dominant-negative form of p38b in Drosophila's most important clock neurons. Western Blots revealed that p38 affects the phosphorylation degree of Period, what is likely the reason for its effects on nuclear entry of Period. In vitro kinase assays confirmed our Western Blot results and point to p38 as a potential "clock kinase" phosphorylating Period. Taken together, our findings indicate that the p38 MAP Kinase is an integral component of the core circadian clock of Drosophila in addition to playing a role in stress-input pathways. KW - in vitro kinase assay KW - biological locomotion KW - circadian oscillators KW - MAPK signaling cascades KW - circadian rhythms KW - drosophila melanogaster KW - neurons KW - phosphorylation Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-119433 SN - 1553-7404 VL - 10 IS - 8 ER - TY - JOUR A1 - Dreyer, Ingo A1 - Gomez-Porras, Judith Lucia A1 - Riaño-Pachón, Diego Mauricio A1 - Hedrich, Rainer A1 - Geiger, Dietmar T1 - Molecular Evolution of Slow and Quick Anion Channels (SLACs and QUACs/ALMTs) JF - Frontiers in Plant Science N2 - Electrophysiological analyses conducted about 25 years ago detected two types of anion channels in the plasma membrane of guard cells. One type of channel responds slowly to changes in membrane voltage while the other responds quickly. Consequently, they were named SLAC, for SLow Anion Channel, and QUAC, for QUick Anion Channel. Recently, genes SLAC1 and QUAC1/ALMT12, underlying the two different anion current components, could be identified in the model plant Arabidopsis thaliana. Expression of the gene products in Xenopus oocytes confirmed the quick and slow current kinetics. In this study we provide an overview on our current knowledge on slow and quick anion channels in plants and analyze the molecular evolution of ALMT/QUAC-like and SLAC-like channels. We discovered fingerprints that allow screening databases for these channel types and were able to identify 192 (177 non-redundant) SLAC-like and 422 (402 non-redundant) ALMT/QUAC-like proteins in the fully sequenced genomes of 32 plant species. Phylogenetic analyses provided new insights into the molecular evolution of these channel types. We also combined sequence alignment and clustering with predictions of protein features, leading to the identification of known conserved phosphorylation sites in SLAC1-like channels along with potential sites that have not been yet experimentally confirmed. Using a similar strategy to analyze the hydropathicity of ALMT/QUAC-like channels, we propose a modified topology with additional transmembrane regions that integrates structure and function of these membrane proteins. Our results suggest that cross-referencing phylogenetic analyses with position-specific protein properties and functional data could be a very powerful tool for genome research approaches in general. KW - anion channel KW - evolution KW - SLAC/SLAH KW - ALMT KW - QUAC KW - voltage dependent KW - topology KW - phosphorylation Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-189345 SN - 1664-462X VL - 3 ER - TY - JOUR A1 - Cui, Huanhuan A1 - Schlesinger, Jenny A1 - Schoenhals, Sophia A1 - Tonjes, Martje A1 - Dunkel, Ilona A1 - Meierhofer, David A1 - Cano, Elena A1 - Schulz, Kerstin A1 - Berger, Michael F. A1 - Haack, Timm A1 - Abdelilah-Seyfried, Salim A1 - Bulyk, Martha L. A1 - Sauer, Sascha A1 - Sperling, Silke R. T1 - Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA JF - Nucleic Acids Research N2 - DPF3 (BAF45c) is a member of the BAF chromatin remodeling complex. Two isoforms have been described, namely DPF3a and DPF3b. The latter binds to acetylated and methylated lysine residues of histones. Here, we elaborate on the role of DPF3a and describe a novel pathway of cardiac gene transcription leading to pathological cardiac hypertrophy. Upon hypertrophic stimuli, casein kinase 2 phosphorylates DPF3a at serine 348. This initiates the interaction of DPF3a with the transcriptional repressors HEY, followed by the release of HEY from the DNA. Moreover, BRG1 is bound by DPF3a, and is thus recruited to HEY genomic targets upon interaction of the two components. Consequently, the transcription of downstream targets such as NPPA and GATA4 is initiated and pathological cardiac hypertrophy is established. In human, DPF3a is significantly up-regulated in hypertrophic hearts of patients with hypertrophic cardiomyopathy or aortic stenosis. Taken together, we show that activation of DPF3a upon hypertrophic stimuli switches cardiac fetal gene expression from being silenced by HEY to being activated by BRG1. Thus, we present a novel pathway for pathological cardiac hypertrophy, whose inhibition is a long-term therapeutic goal for the treatment of the course of heart failure. KW - phosphorylation KW - DPF3a KW - HEY repressors KW - DNA KW - cardiac hypertrophy Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-166391 VL - 44 IS - 6 ER - TY - JOUR A1 - Butt, Elke A1 - Howard, Cory M. A1 - Raman, Dayanidhi T1 - LASP1 in cellular signaling and gene expression: more than just a cytoskeletal regulator JF - Cells N2 - LIM and SH3 protein 1 was originally identified as a structural cytoskeletal protein with scaffolding function. However, recent data suggest additional roles in cell signaling and gene expression, especially in tumor cells. These novel functions are primarily regulated by the site-specific phosphorylation of LASP1. This review will focus on specific phosphorylation-dependent interaction between LASP1 and cellular proteins that orchestrate primary tumor progression and metastasis. More specifically, we will describe the role of LASP1 in chemokine receptor, and PI3K/AKT signaling. We outline the nuclear role for LASP1 in terms of epigenetics and transcriptional regulation and modulation of oncogenic mRNA translation. Finally, newly identified roles for the cytoskeletal function of LASP1 next to its known canonical F-actin binding properties are included. KW - LASP1 KW - AKT KW - CXCR4 KW - structure KW - cytoskeleton KW - phosphorylation KW - transcriptional regulation KW - epigenetics KW - nucleus Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-297447 SN - 2073-4409 VL - 11 IS - 23 ER - TY - JOUR A1 - Budde, Heidi A1 - Hassoun, Roua A1 - Tangos, Melina A1 - Zhazykbayeva, Saltanat A1 - Herwig, Melissa A1 - Varatnitskaya, Marharyta A1 - Sieme, Marcel A1 - Delalat, Simin A1 - Sultana, Innas A1 - Kolijn, Detmar A1 - Gömöri, Kamilla A1 - Jarkas, Muhammad A1 - Lódi, Mária A1 - Jaquet, Kornelia A1 - Kovács, Árpád A1 - Mannherz, Hans Georg A1 - Sequeira, Vasco A1 - Mügge, Andreas A1 - Leichert, Lars I. A1 - Sossalla, Samuel A1 - Hamdani, Nazha T1 - The interplay between S-glutathionylation and phosphorylation of cardiac troponin I and myosin binding protein C in end-stage human failing hearts JF - Antioxidants N2 - Oxidative stress is defined as an imbalance between the antioxidant defense system and the production of reactive oxygen species (ROS). At low levels, ROS are involved in the regulation of redox signaling for cell protection. However, upon chronical increase in oxidative stress, cell damage occurs, due to protein, DNA and lipid oxidation. Here, we investigated the oxidative modifications of myofilament proteins, and their role in modulating cardiomyocyte function in end-stage human failing hearts. We found altered maximum Ca\(^{2+}\)-activated tension and Ca\(^{2+}\) sensitivity of force production of skinned single cardiomyocytes in end-stage human failing hearts compared to non-failing hearts, which was corrected upon treatment with reduced glutathione enzyme. This was accompanied by the increased oxidation of troponin I and myosin binding protein C, and decreased levels of protein kinases A (PKA)- and C (PKC)-mediated phosphorylation of both proteins. The Ca\(^{2+}\) sensitivity and maximal tension correlated strongly with the myofilament oxidation levels, hypo-phosphorylation, and oxidative stress parameters that were measured in all the samples. Furthermore, we detected elevated titin-based myocardial stiffness in HF myocytes, which was reversed by PKA and reduced glutathione enzyme treatment. Finally, many oxidative stress and inflammation parameters were significantly elevated in failing hearts compared to non-failing hearts, and corrected upon treatment with the anti-oxidant GSH enzyme. Here, we provide evidence that the altered mechanical properties of failing human cardiomyocytes are partially due to phosphorylation, S-glutathionylation, and the interplay between the two post-translational modifications, which contribute to the development of heart failure. KW - myofilament proteins KW - oxidative stress KW - inflammation KW - phosphorylation KW - S-glutathionylation Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-242701 SN - 2076-3921 VL - 10 IS - 7 ER - TY - THES A1 - Baljuls, Angela T1 - Differences and Similarities in the Regulation of RAF Isoforms: Identification of Novel A-RAF Phosphorylation Sites T1 - Unterschiede und Ähnlichkeiten in der Regulierung der RAF Isoformen : Identifizierung der neuen A-RAF Phosphorylierungsstellen N2 - In mammals, the RAF family of serine/threonine kinases consists of three members, A-, B- and C-RAF. Activation of RAF kinases involves a complex series of phosphorylations. Although the most prominent phosphorylation sites of B- and C-RAF are well characterized, little is known about regulatory phosphorylation of A-RAF. Using mass spectrometry, we identified here a number of novel in vivo phosphorylation sites in A-RAF. The physiological role and the function of these sites were investigated subsequently by amino acid exchange at the relevant positions. In particular, we found that S432 participates in MEK binding and is indispensable for A-RAF signaling. On the other hand, phosphorylation within the activation segment does not contribute to epidermal growth factor-mediated activation. Regarding regulation of A-RAF activity by 14-3-3 proteins, we show that A-RAF activity is regulated differentially by its C-terminal and internal 14-3-3 binding domain. Furthermore, by use of SPR technique, we found that 14-3-3 proteins associate with RAF in an isoform-specific manner. Of importance, we identified a novel regulatory domain in A-RAF (referred to as IH-segment) positioned between amino acids 248 and 267, which contains seven putative phosphorylation sites. Three of these sites, serines 257, 262 and 264, regulate A-RAF activation in a stimulatory manner. The spatial model of the A-RAF fragment including residues between S246 and E277 revealed a “switch of charge” at the molecular surface of the IH-region upon phosphorylation, suggesting a mechanism in which the high accumulation of negative charges may lead to an electrostatic destabilization of protein/membrane interaction resulting in depletion of A-RAF from the plasma membrane. Activation of B- and C-RAF is regulated by phosphorylation at conserved residues within the negative-charge regulatory region (N-region). Identification of phosphopeptides covering the sequence of the N-region led to the conclusion that, similar to B- and C-RAF, kinase activity of A-RAF is regulated by phosphorylation of the N-region. Abrogation of A-RAF activity by S299A substitution and elevated activity of the A-RAF-Y301D-Y302D mutant confirmed this conclusion. In addition, we studied the role of the non-conserved residues within the N-region in the activation process of RAF kinases. The non-conserved amino acids in positions –3 and +1 relative to the highly conserved S299 in A-RAF and S338 in C-RAF have so far not been considered as regulatory residues. Here, we demonstrate that Y296R substitution in A-RAF led to a constitutively active kinase. In contrast, G300S substitution (mimicking B- and C-RAF) acts in an inhibitory manner. These data were confirmed by analogous mutations in C-RAF. Based on the three-dimensional structure of the catalytic domain of B-RAF, a tight interaction between the N-region residue S339 and the catalytic domain residue R398 was identified in C-RAF and proposed to inhibit the kinase activity of RAF proteins. Furthermore, Y296 in A-RAF favors a spatial orientation of the N-region segment, which enables a tighter contact to the catalytic domain, whereas a glutamine residue at this position in C-RAF abrogates this interaction. Considering this observation, we suggest that Y296, which is unique for A-RAF, is a major determinant of the low activating potency of this RAF isoform. Finally, the residues R359 in A-RAF and R398 in C-RAF, which interact with the N-region, are also involved in binding of phosphatidic acid. Substitution of this conserved arginine by alanine resulted in accumulation of hyper-phosphorylated form of RAF, suggesting that this residue play a crucial role in phosphorylation-mediated feedback regulation of A- and C-RAF. Collectively, we provide here for the first time a detailed analysis of in vivo A-RAF phosphorylation status and demonstrate that regulation of A-RAF by phosphorylation exhibits unique features compared with B- and C-RAF. N2 - Die Protein-Familie der Serin/Threonin-spezifischen RAF-Kinasen umfasst in Säugetieren drei Mitglieder, A-, B- und C-RAF. Bei der Aktivierung dieser Kinasen spielen Phosphorylierungs-ereignisse eine entscheidende Rolle. Im Gegensatz zu B- und C-RAF, deren Phosphorylierungsstellen ausgiebig charakterisiert sind, blieb die Phosphorylierung von A-RAF weitgehend unerforscht. In der vorliegenden Arbeit wurden unter Verwendung der massenspektrometrischen Analyse zahlreiche neue in vivo A-RAF-Phosphorylierungsstellen identifiziert. Die physiologische Relevanz und die Funktion dieser Stellen wurden anschließend durch Aminosäurenaustausch an den relevanten Positionen untersucht. Dabei wurde festgestellt, dass S432 in der A-RAF-Bindung zu MEK involviert und für die Signalweiterleitung unverzichtbar ist. Hingegen ist die EGF-bedingte A-RAF-Aktivierung nicht von der Phosphorylierung innerhalb des Aktivierungssegments abhängig. Hinsichtlich der Regulation von A-RAF-Aktivierung durch 14-3-3-Proteine, wurde hier gezeigt, dass die katalytische Aktivität von A-RAF durch die C-terminale und die interne 14-3-3-Bindungsdomänen unterschiedlich reguliert wird. Weiterhin wurde mittels SPR-Verfahren festgestellt, dass die Interaktion von 14-3-3-Proteinen mit RAF-Kinasen einen isoformspezifischen Charakter trägt. Von entscheidender Bedeutung war die Entdeckung einer neuen regulatorischen Domäne (hier als IH-Segment bezeichnet), die in der A-RAF-Sequenz die Aminosäuren 248 bis 267 umfasst und sieben A-RAF-spezifische Phosphorylierungsstellen enthält. Drei dieser Stellen, S257, S262 und S264, erwiesen sich als positive Regulatoren der A-RAF-Aktivierung. Das räumliche Modell dieses A-RAF-Fragments deckte eine „Ladungsumkehr“ an der molekularen Oberfläche der IH-Region infolge der Phosphorylierung auf. Dieser Befund begründete den Vorschlag eines Regulations-mechanismus, in dem die starke Akkumulierung der negativen Ladungen zu einer elektrostatischen Destabilisierung der Protein-Membran-Interaktion führt, was die Verdrängung der A-RAF-Kinase von der Plasma-Membran zur Folge haben könnte. Die Aktivierung von B- und C-RAF wird durch Phosphorylierung der sogenannten „negativ geladenen“ Region (N-Region) reguliert. Die Identifizierung mehrerer Phosphopeptide aus der N-Region von A-RAF veranlasste die Schlussfolgerung, dass die A-RAF-Aktivität ebenfalls durch die Phosphorylierung innerhalb dieser Region gesteuert werden könnte. In der Tat, die Aufhebung der A-RAF-Aktivität durch die S299A-Substitution und die erhöhte Aktivität der A-RAF-Y301D-Y302D-Mutante bestätigen diese Aussage. Darüberhinaus wurde die Rolle der nichtkonservierten Aminosäuren an den Positionen –3 und +1 relativ zum S299 in A-RAF und S338 in C-RAF im Aktivierungsprozess der RAF-Kinasen untersucht, nachdem diese ursprünglich nicht als regulatorische Stellen erkannt wurden. Es wird hier demonstriert, dass Y296R-Substitution der A-RAF-Kinase eine konstitutive Aktivität verleiht. Hingegen wirkte die G300S-Substitution, die von B- und C-RAF abgeleitet wurde, inhibitorisch. Diese Befunde wurden durch die analogen Mutationen in C-RAF bestätigt. Basierend auf der dreidimensionalen Struktur der katalytischen Domäne von B-RAF wurde eine Interaktion zwischen der N-Region und der katalytischen Domäne in A- und C-RAF festgestellt, die zu einer Inhibierung der Aktivität führen soll. Darüberhinaus wurde gezeigt, dass die räumliche Ausrichtung von Y296 in der N-Region von A-RAF einen engen Kontakt mit der katalytischen Domäne ermöglicht; dagegen hebt Glutamin in dieser Position die Interaktion auf. In Anbetracht dieser Befunde wurde vorschlagen, dass das A-RAF-spezifische Y296 das niedrige Aktivierungs-potential dieser RAF-Isoform determiniert. In diesem Zusammenhang wurde auch gefunden, dass die Aminosäuren R359 in A-RAF und R398 in C-RAF eine duale Funktion besitzen, indem sie sowohl mit der N-Region als auch mit Lipiden in Wechselwirkung treten können. Substitution dieser konservierten Arginine durch Alanin führte zur Akkumulierung der hyperphosphorylierten Formen der RAF-Kinasen, was die Schlussfolgerung erlaubt, dass diese Reste eine wichtige Rolle in der ERK-vermittelten Feedback-Regulation von A- und C-RAF spielen. Insgesamt wird hier zum ersten Mal eine detaillierte Analyse der in vivo A-RAF-Phosphorylierung geliefert und gezeigt, dass die phosphorylierungsvermittelte Regulation von A-RAF einzigartige Merkmale innerhalb der Familie von RAF-Kinasen aufweist. KW - Raf KW - Phosphorylierung KW - Signaltransduktion KW - RAF kinases KW - phosphorylation KW - signal trunsduction Y1 - 2009 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-36135 ER -